T1	Intervention 14 23	meloxicam
T2	Intervention 30 53	glucosamine-chondroitin
T3	Intervention 82 103	feline osteoarthritis
T4	Intervention 108 169	ouble-blind randomised, placebo-controlled, prospective trial
T5	Intervention 209 218	meloxicam
T6	Intervention 225 248	glucosamine-chondroitin
T7	Intervention 290 311	feline osteoarthritis
T8	Intervention 326 374	Prospective, blinded, randomized clinical trial.
T9	Intervention 375 437	Cats over eight years of age with clinical signs of chronic OA
T10	Intervention 477 496	Glu-Ch or meloxicam
T11	Intervention 548 555	placebo
T12	Intervention 570 591	Cats were assessed by
T13	Intervention 594 606	veterinarian
T14	Intervention 610 624	five occasions
T15	Intervention 633 667	owner completed an assessment form
T16	Intervention 694 713	Data were collected
T17	Intervention 726 730	cats
T18	Intervention 732 753	Pre-treatment disease
T19	Intervention 754 760	scores
T20	Intervention 794 803	meloxicam
T21	Intervention 814 828	owner mobility
T22	Intervention 842 861	veterinary lameness
T23	Intervention 878 886	mobility
T24	Intervention 974 987	pre-treatment
T25	Intervention 1003 1012	meloxicam
T26	Intervention 1025 1034	meloxicam
T27	Intervention 1040 1045	lu-Ch
T28	Intervention 1072 1079	placebo
T29	Intervention 1123 1132	meloxicam
T30	Intervention 1167 1180	owner-assesse
T31	Intervention 1237 1243	Glu-Ch
T32	Intervention 1336 1360	Treatment with meloxicam
T33	Intervention 1402 1446	mobility and activity levels of cats with OA
T34	Intervention 1457 1464	placebo
T35	Intervention 1505 1540	cats receiving meloxicam medication
T36	Intervention 1550 1571	significant worsening
T37	Intervention 1575 1598	owner assessment scores
T38	Intervention 1652 1658	Glu-Ch
